{"id":"W4200600309","doi":"10.1111/1759-7714.14281","title":"<scp>Short‐term</scp> safety of an <scp>anti‐severe</scp> acute respiratory syndrome coronavirus 2 messenger <scp>RNA</scp> vaccine for patients with advanced lung cancer treated with anticancer drugs: A multicenter, prospective, observational study","year":2021,"lang":"en","type":"article","venue":"Thoracic Cancer","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Chugai Pharmaceutical; Merck Sharp and Dohme; Bristol-Myers Squibb Canada; Ono Pharmaceutical; Shionogi; Nippon Shinyaku; Astellas Pharma; Boehringer Ingelheim; Nippon Kayaku; Daiichi Sankyo Company; Kyowa Kirin Pharmaceutical Development; Taiho Pharmaceutical; Celgene; Takeda Pharmaceutical Company; Novartis; Pfizer","keywords":"Medicine; Vaccination; Adverse effect; Lung cancer; Internal medicine; Cancer; Coronavirus; Chemotherapy; Immunology; Disease; Coronavirus disease 2019 (COVID-19)","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005746951,0.0009694274,0.001811367,0.0004099408,0.0003930179,0.0001067871,0.0005296189,0.0002877399,0.00004358781],"category_scores_gemma":[0.0005098446,0.000770092,0.000257011,0.001885592,0.0002737768,0.0009079133,0.0002232588,0.0007855418,0.000007047287],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00133149,"about_ca_system_score_gemma":0.002463374,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005931567,"about_ca_topic_score_gemma":0.001425679,"domain_scores_codex":[0.9931551,0.0003119518,0.001160871,0.001813448,0.002143942,0.001414668],"domain_scores_gemma":[0.9933882,0.001062996,0.0006358371,0.001298161,0.003263427,0.0003513889],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002505987,0.00362808,0.9586274,0.0009471927,0.003155174,0.000467308,0.00273517,0.0001332426,0.02209724,0.00001068348,0.000484898,0.005207617],"study_design_scores_gemma":[0.01804271,0.003206202,0.9086502,0.001366688,0.001969592,0.00004032679,0.001998263,0.0007124839,0.05609086,0.000007458294,0.007704921,0.0002103113],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9872206,0.003412124,0.0001194628,0.00004070159,0.0002924016,0.006687663,0.001576883,0.0002056979,0.0004444233],"genre_scores_gemma":[0.9910738,0.0002383188,0.0007966529,0.002659623,0.0002661214,0.003525406,0.0002348242,0.0002995841,0.000905685],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04997722,"threshold_uncertainty_score":0.999475,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04150831443297955,"score_gpt":0.3880192247875337,"score_spread":0.3465109103545542,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}